These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18758641)

  • 1. Bcl-2 expression in Hodgkin's lymphoma progression.
    Flangea C; Potencz E; Mihăescu R; Gîju S; Anghel A
    Rom J Morphol Embryol; 2008; 49(3):357-63. PubMed ID: 18758641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
    Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
    Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mummified Hodgkin and Reed-Sternberg cells in EBV positive and EBV negative Hodgkin's lymphomas, Bcl-2 positivity and evaluation of survival].
    Macák J; Bertová M
    Vnitr Lek; 2001 Mar; 47(3):151-5. PubMed ID: 15635876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of latent membrane protein 1, p53 and bcl-2 proteins and their significance in Hodgkin's lymphoma.
    Qi ZL; Zhao T; Zhou XH; Zhang JH; Han XQ; Zhu MG
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Mar; 23(3):225-7. PubMed ID: 12651235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical drug-resistant nodular sclerosing Hodgkin's lymphoma is associated with decreased bcl-2 expression in the surrounding lymphocytes and with increased bcl-2 expression in the Reed-Sternberg cells.
    van Spronsen DJ; Peh SC; Vrints LW; van Imhoff GW; Poppema S
    Histopathology; 2000 Nov; 37(5):420-6. PubMed ID: 11119123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Localization of apoptosis-antagonizing bcl-2 translated product in Hodgkin's disease].
    Chen XQ; Wang WL; Huang GS
    Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):618-20, 647. PubMed ID: 7842340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Presence of bcl-2 and p53 proteins in patients with non-Hodgkin's lymphoma at Zadar General Hospital].
    Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
    Acta Med Croatica; 2004; 58(3):183-6. PubMed ID: 15503680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
    Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
    Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology.
    Das DK; Francis IM; Sharma PN; Sathar SA; John B; George SS; Mallik MK; Sheikh ZA; Haji BE; Pathan SK; Madda JP; Mirza K; Ahmed MS; Junaid TA
    Diagn Cytopathol; 2009 Aug; 37(8):564-73. PubMed ID: 19373880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty.
    Basu D; Roy SK
    Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hodgkin's disease in Zaire: histological and anatomo-clinical profile].
    Mubikayi L; Kalengayi MM
    IARC Sci Publ; 1984; (63):675-85. PubMed ID: 6536628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan.
    Lee MY; Tan TD; Feng AC
    Clin Lab Haematol; 2005 Dec; 27(6):379-83. PubMed ID: 16307539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases.
    Quiñones-Avila Mdel P; Gonzalez-Longoria AA; Admirand JH; Medeiros LJ
    Am J Clin Pathol; 2005 May; 123(5):651-6. PubMed ID: 15981804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical prognostic factors of primary refractory Hodgkin's lymphoma].
    Filatova LV; Gershanovich ML; Plotnikova AA; Turkevich EA; Ivantsov AO; Klimashevskiĭ VF
    Vopr Onkol; 2014; 60(5):625-9. PubMed ID: 25816669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of cyclooxygenase 2 and Bcl-2 for cervical lymph node metastasis in mucoepidermoid carcinoma.
    Zyada MM; Grawish ME; Elsabaa HM
    Ann Diagn Pathol; 2009 Oct; 13(5):313-21. PubMed ID: 19751908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dural infiltration of metastatic Hodgkin's lymphoma.
    Elwell VA; Carney L; Johns P; Grieve JP
    Br J Neurosurg; 2008 Jun; 22(3):439-40. PubMed ID: 18568736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
    Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical Hodgkin's lymphoma presenting as a testicular mass: report of a case.
    Seliem RM; Chikwava K; Swerdlow SH; Young RH; Ferry JA
    Int J Surg Pathol; 2007 Apr; 15(2):207-12. PubMed ID: 17478785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
    Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
    Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.